Black Ginger — Benefits Deep Dive

Black ginger (Kaempferia parviflora, Thai krachai dam) is sold on three big promises — athletic performance, sexual performance, and metabolic health — all three built on a genuinely unusual and real body of chemistry: the rhizome's polymethoxyflavones, led by 5,7-dimethoxyflavone. The chemistry is not the problem. The gap between what the chemistry demonstrates in a dish or a mouse and what a supplement capsule demonstrably does in a person is where this leg of the site spends its time. Read plainly, the strongest, best-evidenced fact about this herb is not a benefit at all — it is that its own active compounds measurably interfere with a liver enzyme that clears roughly half of all prescription drugs.

Deep-Dive Articles

Back to Table of Contents

Table of Contents

1. Deep-Dive Articles
2. Evidence Ledger for the Whole Leg
3. What the Names Assert
4. Four Ways This Herb Gets Overstated
5. Key Research: Exercise, Muscle and Physical Fitness
6. Key Research: Erectile Function and the PDE5 Mechanism
7. Key Research: Methoxyflavone Chemistry and Pharmacokinetics
8. Key Research: Metabolic Health, Glucose and Brown Fat
9. Key Research: Safety, Interactions and Product Identity
10. External Authoritative Resources
11. Connections

Evidence Ledger for the Whole Leg

Ranked by the strength of the evidence itself, not by how loudly each claim is marketed — which inverts the order a supplement label would use.

1. CYP3A4 inhibition and altered drug pharmacokinetics. Tier: human liver microsomes, two independent research groups, confirmed in live animals, with a repeated-dose study showing the effect does not attenuate. The single best-evidenced fact about this herb, and it is a safety finding, ranked first deliberately. See Methoxyflavone Chemistry and Drug Interactions.
2. Acute brown-fat-mediated energy expenditure increase. Tier: single human study, real PET-verified mechanism, small effect (roughly 55–84 kcal/day), single dose only, effect concentrated in people who already had active brown fat. Genuine physiology, not a weight-loss result. See Metabolic Health.
3. Athletic performance (grip strength) in the soccer-player trial. Tier: one adequately randomised, blinded, placebo-controlled trial — five of six pre-specified measures negative. Closer to a negative verdict for the general performance claim than to "unproven": the trial exists, and it mostly failed. See Exercise Performance and Muscle.
4. Fasting glucose lowering. Tier: meta-analysis of small, heterogeneous trials; human 95% CI runs to −0.05, a hair from zero. A real lead, not a treatment.
5. Erectile function. Tier: a real, replicated, explicitly "low affinity" enzyme finding, plus one small uncontrolled human pilot. This is the doctrine's third verdict in practice — not absent (a trial and a mechanism both exist), not a confirmed negative, but a weak positive that cannot bear the weight the marketing places on it. See Erectile Function and the PDE5 Claim for the arithmetic showing the mechanism is roughly 2,700–7,700 times weaker than an approved drug in the same class.
6. Muscle-protective and anti-adipogenic mechanisms (AMPK, PGC-1α, sarcopenia, adipogenesis). Tier: consistent, mechanistically coherent, entirely preclinical — cell culture and mice only. No human muscle or fat-tissue data of any kind exists for any of these three separate proposed mechanisms.
7. General subchronic toxicity and mutagenicity. Tier: clean 90-day rat study to a formal toxicology standard, negative Ames test. Genuinely reassuring, and a different question entirely from the drug-interaction risk above.
8. The three most solid facts about black ginger are all limitations: no confirmatory trial of the one performance study has appeared in nine years; no dose-finding study exists for any indication; and no shelf product's methoxyflavone content can be trusted without a stated binomial and a percentage, given how many other dark rhizomes share its market.

What the Names Assert

A common name can smuggle in a clinical claim, and checking for it is worth doing on any herb. Black ginger is an instructive case because the check comes back clear on the traditional name and dirty on the marketing name — the opposite pattern from a herb like motherwort or Cissus, where the old name itself makes the claim.

Thai krachai dam means, literally, "black krachai." It describes the rhizome's colour and its relationship to the related plant krachai (fingerroot, without the dam). It asserts nothing about stamina, blood flow or sexual performance. Checked against the pattern this site applies to every herb — does the name pre-load an outcome, biasing every unblinded observer who ever tested it? — black ginger's own name comes back clear, and that is worth stating as a finding in its own right, not just an absence of a problem.

The claim instead lives in an entirely separate, English-language, modern commercial nickname: "Thai Viagra" or "natural Viagra." That name is not a translation of anything Thai, is not attested in the older traditional-medicine literature, and appears to postdate — and to have been built directly on — the 2011 laboratory finding of low-affinity PDE5 inhibition covered in full on the Erectile Function page. This is worth separating cleanly: centuries of traditional use support "a warming tonic, taken generally for stamina and men's health," a vague and largely untestable claim. They do not support "functions like a PDE5-inhibitor drug," which is a 21st-century marketing invention riding on a real but modest laboratory result, not an inheritance from the tradition itself.

Four Ways This Herb Gets Overstated

Each of these is labelled again at the specific point it recurs across the four deep-dive pages, because a reader arriving mid-page, or lifting a single line, should carry the caveat with it rather than the unlabelled version.

1. An in-vitro or animal finding cited as a clinical effect. The single most common error across this whole file. A PDE5 IC50 in an enzyme assay, an AMPK signal in a mouse, an anti-adipogenic result in a cell line — each is real pharmacology and none of them is a demonstrated human outcome. See especially the arithmetic on Erectile Function and PDE5.
2. One positive measure, out of many tested, generalised to the whole claim. The soccer trial's isolated grip-strength result, inconsistent between hands, is the clearest example — five other measures were flat, and the statistics of testing six things at three time points make one crossing significance close to the expected background rate.
3. A single small, uncontrolled human pilot treated as clinical proof. The 14-man erectile-function study is open-label, unblinded, unrandomised and industry-run — a legitimate pilot, and not evidence of efficacy on its own.
4. Compound substitution with citrus polymethoxyflavones. Black ginger's 5,7-dimethoxyflavone and citrus peel's nobiletin and tangeretin are different molecules from unrelated plants that happen to share a structural class; research on one does not automatically transfer to the other. Detailed on Methoxyflavone Chemistry and Drug Interactions.

Back to Table of Contents

Key Research: Exercise, Muscle and Physical Fitness

1. Promthep K, Eungpinichpong W, Sripanidkulchai B, Chatchawan U. Effect of Kaempferia parviflora extract on physical fitness of soccer players: a randomized double-blind placebo-controlled trial. Medical Science Monitor Basic Research, 2015. Read past the abstract — five of six measures were negative. Find on PubMed.
2. Toda K, Hitoe S, Takeda S, Shimoda H. Black ginger extract increases physical fitness performance and muscular endurance by improving inflammation and energy metabolism. Heliyon, 2016. Mouse mechanism: AMPK, PGC-1α, muscle inflammation. Find on PubMed.
3. Kim C, Hwang J-K. The 5,7-dimethoxyflavone suppresses sarcopenia by regulating protein turnover and mitochondria biogenesis-related pathways. Nutrients, 2020. Aged-mouse model; the most specific muscle finding in the file, never tested in humans. Find on PubMed.
4. Leong DP and colleagues (PURE study investigators). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet, 2015. Why grip strength is a validated marker — of mortality risk in a different population, not of athletic performance. Find on PubMed.
5. Saokaew S and colleagues. Clinical effects of Krachaidum (Kaempferia parviflora): a systematic review. Journal of Evidence-Based Complementary and Alternative Medicine, 2017. Find on PubMed.
6. The caffeine and creatine ergogenic-aid literatures, for direct comparison to a much deeper human evidence base. Caffeine · Creatine.

Key Research: Erectile Function and the PDE5 Mechanism

1. Temkitthawon P, Hinds TR, Beavo JA, Viyoch J, et al. Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors. Journal of Ethnopharmacology, 2011. The source of the whole claim — and of the word "low affinity." Find on PubMed.
2. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. International Journal of Impotence Research, 1996. The source of the 3.9 nM comparison figure behind the 2,700–7,700-fold potency gap. Find on PubMed.
3. Stein RA, Schmid K, Bolivar J, Swick AG, et al. Kaempferia parviflora ethanol extract improves self-assessed sexual health in men: a pilot study. Journal of Integrative Medicine, 2018. The only human trial; fourteen men, open-label, uncontrolled. Find on PubMed.
4. Rosen RC, Riley A, Wagner G, Osterloh IH, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 1997. The validated instrument — the study design around it is the problem, not the questionnaire. Find on PubMed.
5. Tep-Areenan P, Sawasdee P, Randall M. Possible mechanisms of vasorelaxation for 5,7-dimethoxyflavone from Kaempferia parviflora in the rat aorta. Phytotherapy Research, 2010. Find on PubMed.
6. Erectile dysfunction as an early marker of cardiovascular disease — why a medical evaluation should come before self-treatment. Search PubMed.

Back to Table of Contents

Key Research: Methoxyflavone Chemistry and Pharmacokinetics

1. Chen D, Li H, Li W, Feng S, et al. Kaempferia parviflora and its methoxyflavones: chemistry and biological activities. Evidence-Based Complementary and Alternative Medicine, 2018. The comprehensive chemistry map behind every other page in this leg. Find on PubMed.
2. Kashiwabuchi Y, Nishimura Y, Kurata N, Iwase M, et al. Inhibition of CYP3A-mediated midazolam metabolism by Kaempferia parviflora. Food Safety (Tokyo), 2022. Human liver microsomes plus rat pharmacokinetics. Find on PubMed.
3. Ochiai W, Kobayashi H, Kitaoka S, Kashiwada M, et al. Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam. Journal of Natural Medicines, 2018. The repeated-dose finding: the CYP3A effect does not wash out. Find on PubMed.
4. Sripanidkulchai B, Mekjaruskul C, Areemit R, Cheawchanwattana A, et al. Glucose tolerance test and pharmacokinetic study of Kaempferia parviflora extract in healthy subjects. Nutrients, 2019. Confirms oral absorption in humans. Find on PubMed.
5. Manthey JA and colleagues. Pharmacokinetic study of nobiletin and tangeretin in rat serum. Journal of Agricultural and Food Chemistry, 2011. A different plant's polymethoxyflavones — cited to illustrate the borrowed-evidence risk. Find on PubMed.

Key Research: Metabolic Health, Glucose and Brown Fat

1. Matsushita M, Yoneshiro T, Aita S, Kamiya T, et al. Kaempferia parviflora extract increases whole-body energy expenditure in humans: roles of brown adipose tissue. Journal of Nutritional Science and Vitaminology, 2015. The 229 kJ/day single-dose finding — roughly a small apple. Find on PubMed.
2. Cypess AM, Lehman S, Williams G, Tal I, et al. Identification and importance of brown adipose tissue in adult humans. New England Journal of Medicine, 2009. The foundational human brown-fat PET study this whole claim rests on. Find on PubMed.
3. Na Takuathung M, Klinjan P, Koonrungsesomboon N. Systematic review and meta-analysis of animal and human studies: metabolic syndrome and erectile dysfunction. Nutrition Research, 2024. The fasting-glucose SMD data, human CI nearly touching zero. Find on PubMed.
4. Zhou G, Myers R, Li Y, Chen Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation, 2001. The mechanism-ceiling comparator for every AMPK claim in this leg. Find on PubMed.
5. Song Y and colleagues. 5,7-Dimethoxyflavone attenuates obesity by inhibiting adipogenesis in 3T3-L1 adipocytes and high-fat-diet-induced obese mice. Journal of Medicinal Food, 2016. Find on PubMed.

Key Research: Safety, Interactions and Product Identity

1. Mekjaruskul C, Jay M, Sripanidkulchai B. Modulatory effects of Kaempferia parviflora extract on mouse hepatic cytochrome P450 enzymes. Journal of Ethnopharmacology, 2012. The earliest independent CYP450 confirmation. Find on PubMed.
2. Mekjaruskul C and colleagues. In vivo effect of Kaempferia parviflora extract on the pharmacokinetics of acetaminophen. Drug and Chemical Toxicology, 2020. A second, independent drug interaction. Find on PubMed.
3. Yoshino S, Awa R, Ohto N, Miyake Y, et al. Toxicological evaluation of standardized Kaempferia parviflora extract: sub-chronic and mutagenicity studies. Toxicology Reports, 2019. The reassuring 90-day rat data. Find on PubMed.
4. Murata K, Deguchi T, Fujita T, Matsuda H. Improvement in blood fluidity by Kaempferia parviflora rhizome. Journal of Natural Medicines, 2013. The fibrinolysis/bleeding-caution mechanism. Find on PubMed.
5. Grapefruit juice and cytochrome P450 3A4 drug interactions — the best-known example of this interaction category. Search PubMed.
6. DNA barcoding and herbal-product authentication — why a marker-compound assay is a potency check, not an identity check, in a market this crowded with similar dark rhizomes. Search PubMed.

Back to Table of Contents

External Authoritative Resources

• NCCIH — National Center for Complementary and Integrative Health; how botanical evidence is graded.
• NIH Office of Dietary Supplements — supplement fact sheets and label literacy.
• LiverTox — drug- and herb-induced liver injury, relevant to the CYP3A4 findings here.
• Urology Care Foundation — patient-level information on erectile dysfunction and its causes.
• NIDDK — obesity, diabetes and metabolic disease information.
• PubMed — search the primary literature directly.

Back to Table of Contents

Connections

• All Herbs
• Black Ginger (Main Page) — botany, names, identification, traditional use, full cautions.
• Exercise Performance and Muscle
• Erectile Function and the PDE5 Claim
• Methoxyflavone Chemistry and Drug Interactions
• Metabolic Health, Blood Sugar and Brown Fat
• Kencur (Kaempferia galanga) — the same genus, a completely different chemistry; the most common mix-up.
• Black Turmeric (Curcuma caesia) — the other black rhizome, a different genus entirely.
• Fingerroot (Boesenbergia rotunda) — plain "krachai" in Thai, without the dam.
• Chen Pi (Aged Citrus Peel) — the other major dietary source of polymethoxyflavones, a different plant.
• Grapefruit — the reference food for CYP3A4 drug interactions.
• Berberine — an AMPK-pathway supplement with far deeper human metabolic trial evidence.
• Arginine for Erectile Function — the nitric-oxide strand of the same claim, with its own trial record.
• Ginseng for Erectile Function — a herb with a considerably larger randomised trial base for the same indication.
• Creatine for Aging and Sarcopenia — real human sarcopenia trial evidence, unlike the mouse-only data here.
• Cold Exposure — the best-established non-pharmacological brown-fat activator.
• Brown Fat Thermogenesis (Interactive)
• Erectile Dysfunction — causes, evaluation and evidence-based treatment.
• Obesity
• Type 2 Diabetes
• Liver Disease — who should avoid this herb given its hepatic enzyme effects.

Back to Table of Contents